Resource Library

Search All Resources

  • Clear All
Common Drug-Drug Interactions with HCV DAAs | June 22, 2022

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #drug interactions  #hcv  #hcv cure  #hcv treatment  #hep c  #hepatitis  

In this presentation, Bradley Moran, PharmD, shares a valuable overview of common medication interactions with hepatitis C medications.

Date added: 06/22/22

HCV 101 | June 2, 2022

Type: Training  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv  #hcv cure  #hcv treatment  #hep c  #hepatitis  

In this training, Dr. Jorge Mera and Whitney Essex discuss screening, treatment and management of patients with hepatitis C at the primary care level through didactic and case presentations, recommendations, and provides an opportunity to become part of a learning ...

Date added: 06/2/22

Indian Country ECHO Treatment Recommendation Analysis | April 27, 2022

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv  #hcv cure  #hcv treatment  #hep c  #hepatitis  

In this presentation, Ashley Wirth, MD/MCR candidate, discusses "Results from an Analysis of Indian Country HCV ECHO Case Forms and Treatment Recommendations" from years 2017-2021. In her presentation she highlights; determining how many patients received treatment recommendations for HCV treatment ...

Date added: 04/27/22

Loved Here, Safe Here Campaign Materials

Type: Handouts  

Audience: Clinical  Community  

Program: Infectious Disease ECHO Program  Trans & Gender Affirming Care ECHO Program  HIV ECHO Program  Hepatitis C  

Keywords: #2slgbtq  #std testing  

The creation of safe, inclusive, and welcoming spaces is critically important to provide holistic wellness for 2SLGBTQ (Two Spirit, lesbian, gay, bisexual, transgender, and queer/questioning) community members. A safe space is a place, program, or community that is intentionally working ...

Date added: 04/12/22

MAT and the HCV Provider | March 23, 2022

Type: Past Presentation  

Program: Hepatitis C  

Keywords: #harm reduction  #hcv treatment  #mat  #OUD  #SUD  

In this presentation Dr. Jessica Gregg provides an overview of screening, treatment options, and individualized care for patients with substance use disorder and hepatitis C virus. The trifecta of interventions needed include treating the HCV infection with antivirals, decreasing the ...

Date added: 03/23/22

Residual Risk for HCC in Patients After HCV SVR | February 23, 2022

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #cure  #hcc  #hepatocellular carcinoma  #svr  

In this presentation, Dr. Raymond Chung, 2021 AASLD President and Director of Hepatology and the Liver Center at Massachusetts General Hospital, discusses the residual risk for hepatocellular carcinoma in patients after achieving cure from hepatitis C virus.

Date added: 02/22/22

Fentanyl’s Rising Presence in Oregon | October 27, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #fentanyl  

In this presentation, guests from Overdose Data to Action: Oregon HOPE discuss the rising prevalence of fentanyl in substances used, share insight from interviews with persons who are currently exposed to risks of fentanyl, and highlight how we may better ...

Date added: 10/27/21

Managing Symptoms During Hepatitis C Treatment (ANTHC)

Type: Handouts  

Audience: Community  

Program: Hepatitis C  Infectious Disease ECHO Program  

Guidance on how to manage many of the common symptoms during hepatitis C treatment.

Date added: 10/20/21

Living with Liver Disease (ANTHC)

Type: Website  

Audience: Community  

Program: Hepatitis C  Infectious Disease ECHO Program  

Keywords: #liver disease  

Resources for patients with Hepatis B, C, or other liver diseases.

Date added: 10/20/21

Practice Guidelines (AALSD)

Type: Website  

Audience: Clinical  

Program: Hepatitis C  Infectious Disease ECHO Program  

Keywords: #hepatology  #liver disease  

American Association for the Study of Liver Diseases practice guidelines which are updated regularly by a committee of hepatology experts and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.

Date added: 10/19/21